Enveda closes $311M Series E funding round
2 Yesterday 6:05 PM · 6h ago · 3 articles · 2 posts · 2 sources · development 2 of 2
The Boulder, Colorado AI biotech closed a $311 million Series E financing round, doubling its valuation to approximately $2 billion. Catalio Capital Management led the round, with participation from new investors including Durable Capital Partners, ICONIQ, Lightspeed, Surveyor Capital, and T. Rowe Price Investment Management, along with existing investors Baillie Gifford, Premji Invest, and Lux Capital. Total capital raised since founding exceeds $845 million.
“The industry has gotten really, really good at commercializing a molecule once you know it's right, but has increasingly gotten worse at finding the right molecule. We're letting AI lead the way for answers that already exist in nature.”
Viswa ColluruViswa Colluru Founder and CEO, EnvedaEnveda AI biotech startupCatalio Capital Management Lead investorAlex Gorsky General partner, ICONIQ; former J&J CEO
The whole story articlesposts the bright band is this development · numbered dots are the others · click one to jump
What was reported 4 claims about this development
-
3 outlets Enveda Raises $311M in Series E Funding
first by FinSMEs, 6h ago · also Yahoo Finance, TechCrunch
2 more headlines
-
first by Quartz, 6h ago · also Business Wire, WSJ Tech
2 more headlines
- Enveda Raises $311 Million From Leading AI and Biotech Investors to Bring Pharma Into the 21st Century Business Wire · 6h ago
- AI Biotech Enveda Doubles in Value to $2 Billion Wall Street Journal · 6h ago
-
first by Quartz, 14h ago
-
first by WSJ, 17h ago
What people said 2 voices · verbatim
-
Get the most important and interesting news from the global economy delivered to your inbox. https:// qz.com/enveda-ai-biotech-raise s-311-million-valuation-2-billion-092326?utm_source=flipboard&utm_medium=activitypub Posted into Business News @ business-news-quartz
-
T
The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s. https:// techcrunch.com/2026/09/23/enve da-secures-311m-to-bring-more-nature-derived-ai-drugs-into-clinical-trials/?utm_source=dlvr.it&utm_medium=mastodon
All 2 developments of Enveda raises $311M at $2B valuation to advance… →
NewswiresMastodonXGoogle News